The research program focuses on the causes and treatment of congenital and acquired mitochondrial diseases, from laboratory-based research to clinical trials. The work is funded by the NIH and FDA. Currently, our main effort is directed to lead a multicenter trial of an investigational drug we have developed for children with a rare, life-threatening, mitochondrial disease. Other areas of related research include drum metabolism, maternal-fetal distress, cancer and sepsis, a life-threatening infection and the commonest cause of mortality in hospitalized patients. All these conditions reflect, in part, fundamental defects in mitochondrial metabolism and function.
Phone: (352) 273-8655